Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is a prescription drug that’s used to treat HIV. This drug can interact with other medications ...
Please provide your email address to receive an email when new articles are posted on . HIV PrEP agents, including long-acting cabotegravir, had no effect on hormonal contraceptives. ViiV Healthcare ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
Morning Overview on MSN
FDA approves Merck’s Idvynso combo pill for HIV treatment
The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV treatment that pairs two drug classes in a single tablet. The approval gives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results